Due to the difference in tumor biology and prognosis between HPV-associated and independent HNSCC, we performed survival analysis separately in p16-positive OPSCC and the above described HPV-negative HNSCC cohort comprising multiple subsites. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.